CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
IOWA Approach Endocardial Ablation Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03700385
NCT03700385N/ACompleted
CompareCT.gov

The IMPULSE Study: A Safety and Feasibility Study of the IOWA Approach Endocardial Ablation System to Treat Atrial Fibrillation

Boston Scientific Corporation·interventional·Posted Oct 9, 2018·Updated Sep 23, 2020

In Brief

A clinical study evaluating IOWA Approach Endocardial Ablation System for Paroxysmal Atrial Fibrillation. Completed, enrolled 40 participants across 2 sites in 2 countries.

Detailed Summary

IMPULSE is a prospective, single-arm, multi-center, safety and feasibility study evaluating the IOWA Approach Endocardial Ablation System (FARAPULSE, Inc.) for the treatment of paroxysmal atrial fibrillation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParoxysmal Atrial Fibrillation
CountriesCzechia, France
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedOct 9, 2018
Enrollment StartJan 19, 2018
Primary CompletionDec 21, 2018
Study CompletionJan 30, 2020
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 7.7 years ago

Interventions

IOWA Approach Endocardial Ablation Systemdevice

Endocardial ablation using the IOWA Approach Endocardial Ablation System